Melanoma

As one of the first skin cancer treatment programs in New York City, we have long been at the forefront of melanoma research and care. We created the ABCDE screening system—now a standard diagnostic tool—to help identify melanoma at an early stage, when treatment is most effective.

Our dermatologists, dermatopathologists, oncologic surgeons, reconstructive plastic surgeons, medical oncologists, radiation oncologists, and pathologists combine their expertise to customize a treatment plan for you.

Our melanoma surgeons specialize in removing the cancer while preserving appearance and function, and our medical oncologists provide the latest targeted treatments, including genetically engineered injectable therapies.

Clinical Trials and Research Studies

Phase 2

A Phase II Open Label Randomized Study of Poly-ICLC Matured DC as an Adjuvant for NY-ESO-1 and Melan-A/MART-1 Peptide Vaccination Compared to Montanide ISA-51 VG in Study Subjects With Melanoma in Complete Clinical Remission But at High Risk of Disease Recurrence

Learn More

Phase 3

A Phase 3 Randomized Study of Adjuvant Immunotherapy with Nivolumab Combined with Ipilimumab Versus Ipilimumab or Nivolumab Monotherapy after Complete Resection of Stage IIIb/c/d or Stage IV Melanoma

Learn More

Phase 2

A Phase 2 Study Of Glembatumumab Vedotin an Anti-gpNMB Antibody-Drug Conjugate as Monotherapy or in Combination with Varlilumab In Patients with Advanced Melanoma

Learn More

Phase 1/2

A Phase 1/2 Open-Label Dose-Escalation Safety and Tolerability Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

Learn More